Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Patent

Techknowgreen Solutions Patent

Techknowgreen Solutions secured a 20-year patent for its 'AIR CLEANING EQUIPMENT' invention. This strengthens the company's intellectual property portfolio and competitive positioning in environmental technology.

Key figures
Execution period20 years
Source

BSE filing, BSE: 543991. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Techknowgreen Solutions Ltd: key numbers

Share price
₹135.15
Market cap
₹99.78 Cr
Revenue (annual)
₹41.07 Cr
Net profit (annual)
₹9.68 Cr
P/E (TTM)
10.3×Sector 22.9×
Promoter holding
65.58%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Techknowgreen Solutions Ltd

All →

Other patent announcements

All →
13:35 IST BSE
PatentAeroflex Industries Ltd AEROFLEX

Aeroflex Industries Patent

Aeroflex Industries secured an Indian patent for automated 3D CAD modeling of braided hose assemblies. The grant underscores its R&D and engineering innovation focus.

18:02 IST BSE
PatentGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Patent

Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.

08:58 IST BSE
PatentGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Patent

Godavari Biorefineries Limited has been granted a patent by the Mexican Patent Office for its invention concerning compounds for treating viral infections.

17:20 IST NSE
PatentUflex Ltd UFLEX

Uflex Patent

UFlex Limited received a patent from the Government of India for its 'High-Speed Twin Aseptic Pack Packaging Machine for Liquid Products'.

10:02 IST BSE
PatentGodavari Biorefineries Ltd GODAVARIB

Godavari Biorefineries Patent

China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.